Precision Nutrition for Alzheimer's Prevention in ApoE4 Carriers

被引:38
|
作者
Norwitz, Nicholas G. [1 ]
Saif, Nabeel [2 ,3 ]
Ariza, Ingrid Estrada [2 ,3 ]
Isaacson, Richard S. [2 ,3 ]
机构
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Weill Cornell Med, Dept Neurol, New York, NY 10065 USA
[3] NewYork Presbyterian, New York, NY 10065 USA
关键词
Alzheimer’ s disease; ApoE4; precision nutrition; astrocytes; microglia; blood– brain barrier; inflammation; insulin resistance; APOLIPOPROTEIN-E EPSILON-4; MILD COGNITIVE IMPAIRMENT; INSULIN-DEGRADING ENZYME; FATTY-ACID-METABOLISM; AMYLOID BETA-PROTEIN; INHIBITS INFLAMMASOME ACTIVATION; DOCOSAHEXAENOIC ACID; VITAMIN-D; MEDITERRANEAN DIET; TAU PATHOLOGY;
D O I
10.3390/nu13041362
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The ApoE4 allele is the most well-studied genetic risk factor for Alzheimer's disease, a condition that is increasing in prevalence and remains without a cure. Precision nutrition targeting metabolic pathways altered by ApoE4 provides a tool for the potential prevention of disease. However, no long-term human studies have been conducted to determine effective nutritional protocols for the prevention of Alzheimer's disease in ApoE4 carriers. This may be because relatively little is yet known about the precise mechanisms by which the genetic variant confers an increased risk of dementia. Fortunately, recent research is beginning to shine a spotlight on these mechanisms. These new data open up the opportunity for speculation as to how carriers might ameliorate risk through lifestyle and nutrition. Herein, we review recent discoveries about how ApoE4 differentially impacts microglia and inflammatory pathways, astrocytes and lipid metabolism, pericytes and blood-brain barrier integrity, and insulin resistance and glucose metabolism. We use these data as a basis to speculate a precision nutrition approach for ApoE4 carriers, including a low-glycemic index diet with a ketogenic option, specific Mediterranean-style food choices, and a panel of seven nutritional supplements. Where possible, we integrate basic scientific mechanisms with human observational studies to create a more complete and convincing rationale for this precision nutrition approach. Until recent research discoveries can be translated into long-term human studies, a mechanism-informed practical clinical approach may be useful for clinicians and patients with ApoE4 to adopt a lifestyle and nutrition plan geared towards Alzheimer's risk reduction.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] mTOR: Alzheimer's disease prevention for APOE4 carriers
    Lin, Ai-Ling
    Butterfield, D. Allan
    Richardson, Arlan
    [J]. ONCOTARGET, 2016, 7 (29) : 44873 - 44874
  • [2] Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers
    Chetelat, G.
    Fouquet, M.
    [J]. REVUE NEUROLOGIQUE, 2013, 169 (10) : 729 - 736
  • [3] APOE4 testing for Alzheimer's disease
    Karlawish, JHT
    Sachs, GA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1153 - 1154
  • [4] A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers
    Bullido, Maria J.
    Martinez-Garcia, Ana
    Artiga, Maria J.
    Aldudo, Jesus
    Sastre, Isabel
    Gil, Pedro
    Coria, Francisco
    Munoz, David G.
    Hachinski, Vladimir
    Frank, Ana
    Valdivieso, Fernando
    [J]. NEUROBIOLOGY OF AGING, 2007, 28 (04) : 519 - 523
  • [5] Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease
    Vance, Jeffery M.
    Farrer, Lindsay A.
    Huang, Yadong
    Cruchaga, Carlos
    Hyman, Bradley T.
    Pericak-Vance, Margaret A.
    Goate, Alison M.
    Greicius, Michael D.
    Griswold, Anthony J.
    Haines, Jonathan L.
    Julia, T. C. W.
    Schellenberg, Gerard D.
    Tsai, Li-Huei
    Herz, Joachim
    Holtzman, David M.
    [J]. ANNALS OF NEUROLOGY, 2024, 95 (04) : 625 - 634
  • [6] Cortical Transcriptional Profiles in APOE4 Carriers with Alzheimer's Disease: Patterns of Protection and Degeneration
    Conejero-Goldberg, Concepcion
    Hyde, Thomas M.
    Chen, Shufen
    Herman, Mary M.
    Kleinman, Joel E.
    Davies, Peter
    Goldberg, Terry E.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 48 (04) : 969 - 978
  • [7] THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION STUDY: A PRECLINICAL TRIAL IN APOE4 HOMOZYGOTES
    Tariot, P. N.
    Langbaum, J.
    Reiman, E.
    Graf, A.
    Lopez, C. Lopez
    Ryan, M.
    [J]. GERONTOLOGIST, 2016, 56 : 626 - 627
  • [8] The Alzheimer's Prevention Initiative Generation Study: A Preclinical Trial in APOE4 Homozygotes
    Tariot, Pierre
    Langbaum, Jessica
    Schneider, Lon
    Thomas, Ronald G.
    Graf, Ana
    Lopez-Lopez, Cristina
    Caputo, Angelika
    Lenz, Robert
    Vargas, Gabriel
    Reiman, Eric M.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S139 - S139
  • [9] ApoE4: A RISK FACTOR FOR ALZHEIMER'S DISEASE
    Agarwala, A.
    Durakoglugil, M.
    Xian, D.
    Bowen, I
    Herz, J.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (02) : 469 - 469
  • [10] TIMely connections: APOE4, aging, and Alzheimer's
    Li, Qingyun
    [J]. IMMUNITY, 2024, 57 (01) : 8 - 10